These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27340112)

  • 1. Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial.
    Gingnell M; Frick A; Engman J; Alaie I; Björkstrand J; Faria V; Carlbring P; Andersson G; Reis M; Larsson EM; Wahlstedt K; Fredrikson M; Furmark T
    Br J Psychiatry; 2016 Sep; 209(3):229-35. PubMed ID: 27340112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging, genetic, clinical, and demographic predictors of treatment response in patients with social anxiety disorder.
    Frick A; Engman J; Alaie I; Björkstrand J; Gingnell M; Larsson EM; Eriksson E; Wahlstedt K; Fredrikson M; Furmark T
    J Affect Disord; 2020 Jan; 261():230-237. PubMed ID: 31655378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered neural correlates of affective processing after internet-delivered cognitive behavior therapy for social anxiety disorder.
    Månsson KN; Carlbring P; Frick A; Engman J; Olsson CJ; Bodlund O; Furmark T; Andersson G
    Psychiatry Res; 2013 Dec; 214(3):229-37. PubMed ID: 24064198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.
    Hjorth O; Frick A; Gingnell M; Engman J; Björkstrand J; Faria V; Alaie I; Carlbring P; Andersson G; Jonasson M; Lubberink M; Antoni G; Reis M; Wahlstedt K; Fredrikson M; Furmark T
    Transl Psychiatry; 2022 Oct; 12(1):436. PubMed ID: 36202797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.
    Lu L; Mills JA; Li H; Schroeder HK; Mossman SA; Varney ST; Cecil KM; Huang X; Gong Q; Ramsey LB; DelBello MP; Sweeney JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Oct; 60(10):1309-1318. PubMed ID: 33548492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting long-term outcome of Internet-delivered cognitive behavior therapy for social anxiety disorder using fMRI and support vector machine learning.
    Månsson KN; Frick A; Boraxbekk CJ; Marquand AF; Williams SC; Carlbring P; Andersson G; Furmark T
    Transl Psychiatry; 2015 Mar; 5(3):e530. PubMed ID: 25781229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial.
    Lu L; Li H; Baumel WT; Mills JA; Cecil KM; Schroeder HK; Mossman SA; Huang X; Gong Q; Sweeney JA; Strawn JR
    Neuropsychopharmacology; 2022 Apr; 47(5):1081-1087. PubMed ID: 34580419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
    Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial.
    Gorka SM; Young CB; Klumpp H; Kennedy AE; Francis J; Ajilore O; Langenecker SA; Shankman SA; Craske MG; Stein MB; Phan KL
    Neuropsychopharmacology; 2019 Aug; 44(9):1639-1648. PubMed ID: 31060042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study.
    Schneier FR; Belzer KD; Kishon R; Amsel L; Simpson HB
    J Nerv Ment Dis; 2010 Jun; 198(6):458-61. PubMed ID: 20531128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial.
    Hedman E; Andersson G; Ljótsson B; Andersson E; Rück C; Mörtberg E; Lindefors N
    PLoS One; 2011 Mar; 6(3):e18001. PubMed ID: 21483704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial.
    Jolstedt M; Wahlund T; Lenhard F; Ljótsson B; Mataix-Cols D; Nord M; Öst LG; Högström J; Serlachius E; Vigerland S
    Lancet Child Adolesc Health; 2018 Nov; 2(11):792-801. PubMed ID: 30241993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study.
    Cremers H; Lee R; Keedy S; Phan KL; Coccaro E
    Neuropsychopharmacology; 2016 Jan; 41(2):590-7. PubMed ID: 26105140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.
    Lenze EJ; Rollman BL; Shear MK; Dew MA; Pollock BG; Ciliberti C; Costantino M; Snyder S; Shi P; Spitznagel E; Andreescu C; Butters MA; Reynolds CF
    JAMA; 2009 Jan; 301(3):295-303. PubMed ID: 19155456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.
    Kasper S; Stein DJ; Loft H; Nil R
    Br J Psychiatry; 2005 Mar; 186():222-6. PubMed ID: 15738503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.